Autopsy report · NCT03288792

A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts

“Sponsor decision, not safety related”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 1 year before it stopped.
• 435 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Real Imaging Ltd.

Sponsor type

Industry

Conditions

Breast Cancer

Interventions

RI8 device imaging

Participants

435

Sites

5

Countries

United States

Trials that died the same way

• NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
  “sponsor decision (not for safety)” (97% match in meaning)
• Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
  “Sponsor decision (not due to safety concerns)” (96% match in meaning)
• XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
  “Sponsor decision; Not a safety decision” (96% match in meaning)
• (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
  “Sponsor decision, not related to safety concerns” (95% match in meaning)
• Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
  “Sponsor decision not related to safety reasons” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.